James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

“Haunted” Mylan N.V. (MYL) Stock Is Due for More Pain

Mylan (MYL) may have a nice track record of growth thanks to the EpiPen, but legal headwinds and general decency pose a significant threat to MYL stock.

Why Horizon Pharma (HZNP), Liberty Global (LBTYA) and Melco Resorts (MLCO) Are 3 of Today’s Worst Stocks

Horizon Pharma (HZNP), Liberty Global (LBTYA) and Melco Resorts & Entertainment (MLCO) each got the new trading week started on the wrong foot.

Chesapeake Energy Corporation (CHK) Stock Is a Long-Term Beast

CHK stock has been rocked and rolled in recent weeks, but it shouldn't matter. True fans of Chesapeake Energy are keeping an eye on the bigger prize.

Why International Business Machines Corp. (IBM), Juno Therapeutics Inc (JUNO) and LendingClub Corp (LC) Are 3 of Today’s Worst Stocks

International Business Machines (IBM), Juno Therapeutics (JUNO) and LendingClub (LC) shareholders couldn't wait for to the week to end.

It’s Time to Rethink Berkshire Hathaway Inc. (BRK.B) Stock

Buffett has made Berkshire Hathaway (BRK.A, BRK.B) a permanent fixture of investing, but BRK.B stock looks different today.